Hydrolysis by cathepsin B of fluorescent peptides derived from human prorenin.

Cathepsin B is a lysosomal thiolprotease that, because of its colocalization with renin and its ability to activate prorenin, has been proposed as a prorenin processing enzyme. To characterize the biochemical aspect of this potential cathepsin B activity in more detail, we synthesized and assayed with human cathepsin B the internally quenched fluorescent peptide Abz-FSQPMKRLTLGNTTQ-EDDnp (Abz, ortho-aminobenzoic acid fluorescent group and EDDnp, N-¿2, 4-dinitrophenyl-ethylenediamine quencher group) that contains 7 amino acids for each side of the R-L bond that is the processing site of human prorenin. Human cathepsin B hydrolyzed this peptide at the correct site (R-L bond), with k(cat)/K(m)=75 mmol/L(-1) s(-1). Analogues of this peptide obtained by Ala scanning at positions P(5) to P(5)' were also synthesized and assayed as substrates for human cathepsin B. The obtained specificity constant (k(cat)/K(m)) values have a significant parallel with the previous data of prorenin activation by AtT-20 cells and in vitro by cathepsin B. In addition, we demonstrated the presence of cathepsin B-like activity in rat mesangial cells and the ability of its whole soluble fraction lysates, as well as that of purified cloned rat cathepsin B, to hydrolyze Abz-IKKSSF-EDDnp at the K-S bond, which contains 6 amino acids of rat prorenin processing site. The specificity data of cathepsin B toward peptides derived from prorenin processing site support the view that human or rodent cathepsin B could be involved in the intracellular processing of prorenin that is locally synthesized or taken up from the extracellular compartment.

[1]  A. Danser,et al.  Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. , 1994, Hypertension.

[2]  N. Niedermaier,et al.  Cardiac angiotensinogen and its local activation in the isolated perfused beating heart. , 1990, Circulation research.

[3]  R. Coulombe,et al.  RAT PROCATHEPSIN B , 1997 .

[4]  N. Fukuda,et al.  Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[5]  A. Berger,et al.  On the size of the active site in proteases. I. Papain. , 1967, Biochemical and biophysical research communications.

[6]  J. Habener,et al.  Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. , 1986, The Journal of clinical investigation.

[7]  C. Krakower,et al.  Direct evidence for the antigenicity of the glomeruli in the production of nephrotoxic serums. , 1950, A.M.A. archives of pathology.

[8]  I. Jutras,et al.  Prorenin activation and prohormone convertases in the mouse As4.1 cell line. , 1997, Kidney international.

[9]  J. Baxter,et al.  Molecular determinants of human prorenin processing. , 1992, Hypertension.

[10]  T. Brody,et al.  Tissue‐Specific Regulation of Renin Expression in the Mouse , 1987, Hypertension.

[11]  J. Baxter,et al.  A Protease Processing Site Is Essential for Prorenin Sorting to the Regulated Secretory Pathway* , 1996, The Journal of Biological Chemistry.

[12]  I. Jutras,et al.  Prohormone convertase PC5 is a candidate processing enzyme for prorenin in the human adrenal cortex. , 1996, Hypertension.

[13]  E. Shaw,et al.  [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl☆ , 1970 .

[14]  A. Danser,et al.  Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. , 1997, Hypertension.

[15]  M. Schalekamp,et al.  Human prorenin: pathophysiology and clinical implications. , 1988, Clinical and experimental hypertension. Part A, Theory and practice.

[16]  M. Schalekamp,et al.  An intrinsic factor XII–prekallikrein-dependent pathway activates the human plasma renin–angiotensin system , 1979, Nature.

[17]  W. Ganong,et al.  Analysis by immunocytochemistry and in situ hybridization of renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D. Casarini,et al.  Purification and characterization of angiotensin I‐converting enzymes from mesangial cells in culture , 1998, Journal of hypertension.

[19]  H. Thurston,et al.  Arterial wall uptake of renal renin and blood pressure control. , 1983, Hypertension.

[20]  W. Hsueh,et al.  Human Prorenin , 1991, Hypertension.

[21]  J. Berrou,et al.  Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. , 1996, Kidney international.

[22]  J. Mort,et al.  Rat procathepsin B. Proteolytic processing to the mature form in vitro. , 1992, The Journal of biological chemistry.

[23]  A. Danser,et al.  Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. , 1997, Hypertension.

[24]  R. Ardaillou,et al.  Identification and regulation of renin in human cultured mesangial cells. , 1987, The American journal of physiology.

[25]  L. Chao,et al.  Specificity of human tissue kallikrein towards substrates containing Phe-Phe pair of amino acids. , 1999, Biochemical Journal.

[26]  G. N. Wilkinson Statistical estimations in enzyme kinetics. , 1961, The Biochemical journal.

[27]  J. Laragh,et al.  Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin , 1978, Nature.

[28]  R. Ménard,et al.  Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. , 1997, Biochemistry.

[29]  J. Saris,et al.  Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II. , 1999, Cardiovascular research.

[30]  W. Ganong Blood, Pituitary, and Brain Renin-Angiotensin Systems and Regulation of Secretion of Anterior Pituitary Gland , 1993, Frontiers in Neuroendocrinology.

[31]  W. Hsueh,et al.  Identification of renal cathepsin B as a human prorenin-processing enzyme. , 1991, The Journal of biological chemistry.

[32]  I. Jutras,et al.  Prorenin processing by cathepsin B in vitro and in transfected cells , 1999, FEBS letters.

[33]  W. Rutter,et al.  Redesigning trypsin: alteration of substrate specificity. , 1985, Science.

[34]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[35]  A. Barrett,et al.  Cathepsin B, Cathepsin H, and cathepsin L. , 1981, Methods in enzymology.

[36]  Alan J. Barrett,et al.  [41] Cathepsin B, cathepsin H, and cathepsin L , 1981 .

[37]  C. L. Dias,et al.  Autolysis of beta-trypsin at pH 3.0. , 1986, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[38]  A. Barrett Fluorimetric assays for cathepsin B and cathepsin H with methylcoumarylamide substrates. , 1980, The Biochemical journal.

[39]  F. A. Neves,et al.  Cathepsin B is a prorenin processing enzyme. , 1996, Hypertension.